General Gustave F. Perna, who heads the operation of Operation Warp Speed, the federal vaccine distribution effort, told reporters Monday that officials were ready to deal with any problems that could disrupt smooth deliveries, including fake delivery addresses and truck or plane accidents. June 9: HHS and DoD announced a joint effort to increase the national production capacity of vials that may be needed for vaccines and treatments Recently, two of the four test vaccine candidates (BNT162b1 and BNT162b2) have been awarded the fast-track label of the U.S. Food and Drug Administration (FDA). This term was given on the basis of preliminary data from phase 1/2 studies currently underway in the United States and Germany, as well as on animal immunogenicity studies. Further data from the ongoing Phase 1/2 clinical studies of the four vaccine candidates will be used to select a primary candidate and dose level for a large overall safety and efficacy study of Phase 2b/3 expected, which may begin this month until no marketing authorization is available. Hospitals across the country, which waited for the first few doses for months, quickly tried to compile events after unknowns about the vaccine and its distribution made it difficult to plan for its arrival. At Ohio State University`s Wexner Medical Center, Dr. Mercy Dickson, a 35-year-old resident of emergency medicine, said she felt good, even after working nights before and after receiving the vaccine. Two giant rivals, UPS and FedEx, are working side by side to deliver the Covid 19 vaccine to Pfizer`s plant vaccination sites in Michigan and Wisconsin. A UPS spokesman, Matthew O`Connor, said the company had a team of meteorologists monitoring the weather 24 hours a day. “We are pleased to have signed this important agreement with the U.S.

government to provide the first 100 million doses after authorization as part of our commitment to combat the global health threat. This agreement is one of many steps to ensure access to safe and effective vaccines for COVID-19 worldwide. We are also in advanced talks with several other government agencies and hope to announce further procurement agreements soon. Our goal remains to bring a safe and effective COVID 19 vaccine to many people around the world as quickly as possible,” said Ugur Sahin, CEO and co-founder of BioNTech. “There is nothing at this stage about the storm that should disrupt the supply of vaccines,” he said. The Trump administration is discussing helping the drug maker obtain the raw materials needed to produce tens of millions more doses of its Covid 19 vaccine in the spring. The New York Times first reported on Monday negotiations on other doses and said Pfizer was offering the U.S. government between 100 million and 500 million additional doses and warned that its vaccine could be rare given demand worldwide. As a result, a second allocation for the United States could not be available until June of next year. The $21 per dose, under-induced by the Sanofi-GSK agreement, is higher than the amount that the government bioNTech and Pfizer, Novavax, Johnson-Johnson and AstraZeneca must pay for the vaccines. These players have U.S. government contracts that work at prices per dose of 4 to 19.50 $US.

Dr. Fauci said he would also recommend that President Trump and Vice President Mike Pence receive the vaccine, even though the president already had covid-19. Between $12 and $25, the price per dose is the top end of what the U.S. government pays for other vaccines. Last month, the U.S. government agreed to provide Sanofi and GlaxoSmithKline with up to $2.1 billion to support the development and production of their vaccine, securing 100 million doses of delivery.